Vilin Bio Med Limited (NSE:VILINBIO)

India flag India · Delayed Price · Currency is INR
38.10
+0.70 (1.87%)
Apr 29, 2026, 1:14 PM IST
36.07%
Market Cap 531.50M
Revenue (ttm) 199.81M
Net Income (ttm) 2.51M
Shares Out 13.95M
EPS (ttm) 0.18
PE Ratio 211.94
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,000
Average Volume 15,200
Open 38.10
Previous Close 37.40
Day's Range 38.10 - 38.10
52-Week Range 18.95 - 38.40
Beta 0.53
RSI 58.99
Earnings Date May 15, 2026

About Vilin Bio Med

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non beta lactam tablets and capsules, and nutritional food... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2005
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol VILINBIO
Full Company Profile

Financial Performance

In fiscal year 2025, Vilin Bio Med's revenue was 148.10 million, a decrease of -6.30% compared to the previous year's 158.05 million. Earnings were 2.24 million, an increase of 37.62%.

Financial Statements

News

There is no news available yet.